CUSTOMER QUOTES

Find out more about what our customers say about our technology.

AstraZeneca

"We have been working with InforSense on point solutions and we are looking forward to collaborate with them in using their integrated informatics platform in one of our protein class programs. InforSense's technology will enable us to create efficiently an informatics environment for our complex discovery needs which spans multiple scientific disciplines, data sources and experimental platforms. Our goal in this project is to understand all relevant aspects of the protein family under investigation and produce knowledge which can be exploited throughout our drug discovery research."

Dr Per Falk
Director for Molecular Biology at AstraZeneca R&D Molndal

"We have recognized the potential value of InforSense integrative analytics technology at AstraZeneca for effective research decision-making over recent years. By expanding our commitment to InforSense, we will empower more scientists across our organization to effectively use information-driven analytics to inform and accelerate their research."

Martyn Wilkins
Director of Discovery Informatics Portfolio at AstraZeneca

Bayer

"To identify and optimize potential drug leads, Bayer's chemists need both rapid processing of large compound libraries via chemical cartridge technology coupled with easy access to best of breed proprietary and third party analytic tools and visualizations. …[InforSense] technology offers the appropriate environment for rapidly composing data and applications, including our in-house in silico ADMET tools, to optimize our high-throughput cheminformatics analysis."

Dr. Alexander Hillisch
Head of Computational Chemistry at Bayer Healthcare AG

Boehringer Ingelheim

"… [InforSense’s] proven multi-platform integration will enable us to exploit our existing informatics investment and provide a highly extensible discovery environment for the future."

Herbert Köppen
Head of Chemoinformatics, Boehringer Ingelheim

GlaxoSmithKline

"Our scientists have to deal with growing quantities of data. The more efficient we are at processing these data, the better will be our decision making. The challenge is both to facilitate this dynamic and iterative process and at the same time capture the key decisions that are made so they can be improved over time."

Stephen Calvert
Vice President, Cheminformatics at GSK

"An organization like GSK must also ensure that the IT infrastructure we build is both scalable and maintainable. InforSense workflow technology provides a scalable integration solution, enabling our scientists to develop, enhance and share discovery services. With InforSense we will ensure that the technology we build our infrastructure upon is an industry standard."

Stephen Calvert
Vice President, Cheminformatics at GSK

"… InforSense workflow technology provides a scalable integration solution, enabling our scientists to develop, enhance and share discovery services. With InforSense, we will ensure that the technology we build our infrastructure upon is an industry standard."

Stephen Calvert
Vice President, Cheminformatics at GSK

"InforSense is different from traditional technologies because you can build it as you go. The scientists now have an environment that they can modify themselves."

Stephen Calvert
Vice President, Cheminformatics at GSK

Hospital for Sick Children, Toronto

(The Centre for Applied Genomics Microarray Facility)

"The InforSense platform is comprehensive and flexible. We find the [InforSense technology] approach of Open Discovery Workflows to be very intuitive and powerful, and the enterprise system promotes collaboration."

Chao Lu
Manager & Analyst, TCAG Microarray Facility

McGill University & Genome Quebec Innovation Centre

"For a group like ours that handles thousands of Gene Expression experiments, the InforSense solution is extremely valuable. In a field where it is difficult to find a viable solution from either the commercial or public domain, InforSense technology actually does the job."

Tibor van Rooij
McGill University & Genome Quebec Innovation Centre

National Cancer Institute (NCI) (USA)

"Investigators require access to the latest analysis techniques to advance their research. Therefore, creating the informatics infrastructure to compose and deliver these methods is a high priority at the CGF. After an extensive review of the available commercial and open source options, we recognized that InforSense is able to provide the functionality, flexibility, and scalability we need to support our research, and to develop caBIG™ (Cancer Biomedical Informatics Grid ) compatible applications."

Dr. Meredith Yeager
Scientific Director, Core Genotyping Facility, NCI

Shanghai Public Infrastructure for Research and Development Service, STCSM

"InforSense is the only supplier to offer such a highly open, flexible and scalable integrative informatics environment. This is the initial step to fulfill our vision of delivering automated integration, analysis and interpretation of diverse data for the benefit of our entire scientific and technical community."

Yixue Li
General Project Leader of the Shanghai Public Infrastructure for Research and Development Service, STCSM

Syngenta

"After a thorough and competitive analysis, we selected InforSense software because, right out-of-the-box, it delivers a core of research-relevant, integrative analytic capabilities that give us an information advantage in novel agricultural discovery. In addition, InforSense’s Professional Services group demonstrated its ability to help us efficiently customize the solution to fit into our existing data management processes and infrastructure."

Dr. John Chan
Syngenta’s Head of Global Bioinformatics

Unilever

"We are pleased to be working with InforSense again, having proved the value of their text-mining technology to our business. TextSense's flexible workflow-centric approach enables us to capture knowledge without dictating the process, empowering end-users to solve real research challenges."

Lawrence Barratt
Head of Knowledge and Information Sciences at Unilever R&D Colworth

Windber Research Institute (WRI)

"InforSense workflow technology will enable us to build solutions that are flexible enough to support the dynamic and iterative thought processes of our scientists. Combined with the ability to then deploy these findings throughout our research teams, InforSense technology will enable our scientists to translate their research into real decisions that can impact patient care."

Prof. Michael Liebman
CSO, Windber Research Institute